Klein, Thomas |
NCT06098079: Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE) |
|
|
| Recruiting | 4 | 8600 | US | Naltrexone-Bupropion (NB) Combination, Placebo | Currax Pharmaceuticals | Obesity | 01/29 | 07/29 | | |
NCT05264506: Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive |
|
|
| Terminated | 3 | 2007 | US | NOMAC-E2 COC, Nomegestrol acetate / estradiol | Organon and Co, IQVIA Inc., OSTAtistics | Contraception | 01/24 | 01/24 | | |
MARS-17, NCT05838742: A Dose-Finding Study to Evaluate the Efficacy and Safety of GSK3858279 in Adults With Knee Osteoarthritis Pain |
|
|
| Active, not recruiting | 2 | 263 | Europe, Canada, Japan, US, RoW | GSK3858279, Placebo | GlaxoSmithKline | Pain, Osteoarthritis, Knee | 08/24 | 11/24 | | |
| Recruiting | 2 | 282 | Europe, Canada, US, RoW | GSK4527226, Placebo | GlaxoSmithKline, Alector Inc. | Alzheimer's Disease | 12/26 | 05/29 | | |
TicTac, NCT05783895: Comparison of Pre-test Probability Model for Heparin-induced Thrombocytopenia in Post-operative Cardiac Surgery |
|
|
| Recruiting | N/A | 200 | Europe | Post screening diagnostic test | Central Hospital, Nancy, France | Heparin-induced Thrombocytopenia | 03/23 | 06/23 | | |
LevoCV, NCT06021587: Interest of Levosimendan Preconditioning for Cardiac Surgery Under CEC in Heart Failure Patients With Impaired Ejection Fraction |
|
|
| Recruiting | N/A | 300 | Europe | Levosimendan, Interventional, No Levosimendan, Control | Central Hospital, Nancy, France | Levosimendan, Cardiac Surgery, Heart Failure With Reduced Ejection Fraction | 07/23 | 10/23 | | |
HypoLungECMO, NCT05306392: Effects of Induced Moderate Hypothermia on ARDS Patients Under Venovenous ExtraCorporeal Membrane Oxygenation |
|
|
| Not yet recruiting | N/A | 30 | NA | Moderate Hypothermia, Normothermia | Central Hospital, Nancy, France | ARDS, Human, Extracorporeal Membrane Oxygenation Complication, Hypothermia | 03/24 | 09/24 | | |
| Recruiting | N/A | 3000 | US | Treatment Recommendation Surveys, 7-gene biosignature | PreludeDx, University of South Florida | DCIS | 12/25 | 12/35 | | |
Thomas, KLEIN |
TicTac, NCT05783895: Comparison of Pre-test Probability Model for Heparin-induced Thrombocytopenia in Post-operative Cardiac Surgery |
|
|
| Recruiting | N/A | 200 | Europe | Post screening diagnostic test | Central Hospital, Nancy, France | Heparin-induced Thrombocytopenia | 03/23 | 06/23 | | |
LevoCV, NCT06021587: Interest of Levosimendan Preconditioning for Cardiac Surgery Under CEC in Heart Failure Patients With Impaired Ejection Fraction |
|
|
| Recruiting | N/A | 300 | Europe | Levosimendan, Interventional, No Levosimendan, Control | Central Hospital, Nancy, France | Levosimendan, Cardiac Surgery, Heart Failure With Reduced Ejection Fraction | 07/23 | 10/23 | | |
LevoCCV, NCT05685537: Impact of Levosimendan Preconditioning on Critical Care and In-hospital Lengths of Stay After Cardiac Surgery With Bypass Surgery |
|
|
| Recruiting | N/A | 120 | Europe | Levosimendan, Interventional | Central Hospital, Nancy, France | Levosimendan, Cardiac Surgery, Cardiopulmonary Bypass | 12/22 | 02/23 | | |